Haridhasapavalan K, Sundaravadivelu P, Joshi N, Das N, Mohapatra A, Voorkara U, et al. Generation of a recombinant version of a biologically active cell-permeant human HAND2 transcription factor from E. coli. Sci Rep. 2022;12:16129 pubmed publisher

Carola G, Malagarriga D, Calatayud C, Pons Espinal M, Blasco Agell L, Richaud Patin Y, et al. Parkinson's disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration. NPJ Parkinsons Dis. 2021;7:55 pubmed publisher

Venkatesh S, Baljinnyam E, Tong M, Kashihara T, Yan L, Liu T, et al. Proteomic analysis of mitochondrial biogenesis in cardiomyocytes differentiated from human induced pluripotent stem cells. Am J Physiol Regul Integr Comp Physiol. 2020;: pubmed publisher

Chen X, Wang L, Huang R, Qiu H, Wang P, Wu D, et al. Dgcr8 deletion in the primitive heart uncovered novel microRNA regulating the balance of cardiac-vascular gene program. Protein Cell. 2019;10:327-346 pubmed publisher

Christoforou N, Chellappan M, Adler A, Kirkton R, Wu T, Addis R, et al. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS ONE. 2013;8:e63577 pubmed publisher

Pol S, Lang J, O Bara M, Cimato T, McCallion A, Sim F. Sox10-MCS5 enhancer dynamically tracks human oligodendrocyte progenitor fate. Exp Neurol. 2013;247:694-702 pubmed publisher

Ou D, Zeng D, Jin Y, Liu X, Teng J, Guo W, et al. The long-term differentiation of embryonic stem cells into cardiomyocytes: an indirect co-culture model. PLoS ONE. 2013;8:e55233 pubmed publisher

Kita Matsuo H, Barcova M, Prigozhina N, Salomonis N, Wei K, Jacot J, et al. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS ONE. 2009;4:e5046 pubmed publisher